Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | Six Months Ended May 31, 2026 | Six Months Ended May 31, 2025 |
|---|---|---|
| Cash flows from investing activities | ||
| Purchases of marketable securities | (280,562) | (178,351) |
| Maturities of marketable securities | 252,714 | 281,543 |
| Purchases of property and equipment | (2,981) | (6,160) |
| Net cash provided by (used in) investing activities | (30,829) | 97,032 |
| Cash flows from financing activities | ||
| Proceeds from exercise of stock options | 441 | 227 |
| Proceeds from issuance of common stock under employee stock purchase plan | 1,596 | 1,252 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s capex?
- Nurix Therapeutics, Inc. (NRIX) reported capex of $1.94M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s capex changed year-over-year?
- Nurix Therapeutics, Inc.'s capex decreased by 27.6% year-over-year, from $2.68M to $1.94M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s capex?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s capex has grown at a 25.4% compound annual growth rate (CAGR), from $5.66M to $14M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Nurix Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude